An apparent case of human T-cell lymphotropic virus type II (HTLV-II)-associated neurological disease: A clinical, molecular, and phylogenetic characterisation

Journal of Clinical Virology

Volumn 14, Issue 1, 1999, Pages 37-50

  Peters, Andrew A ^a,b   Oger, Joel J F ^c   Coulthart, Michael B ^d   Waters, David J ^e   Cummings, Heather J ^a   Dekaban, Gregory A ^a,b  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d HEALTH CANADA   (Canada)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Ataxia; HTLV II; Myelopathy; Neurological disease; Phylogenetic tree

Indexed keywords

ADULT; ARTICLE; ATAXIA; CASE REPORT; CEREBROSPINAL FLUID; DNA SEQUENCE; ENVELOPE GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 2; LONG TERMINAL REPEAT; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPINAL CORD DISEASE; VIRAL GENETICS;

ATAXIA; BASE SEQUENCE; DNA; FEMALE; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEROLOGIC TESTS; SPINAL CORD DISEASES; TERMINAL REPEAT SEQUENCES;

EID: 0032828085     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(99)00041-4     Document Type: Article

References (54)

1. Berger J.R., Svenningsson A., Raffanti S., Resnick L. Tropical spastic paraparesis-like illness occurring in a patient dually infected with HIV-1 and HTLV-II. Neurology. 41:1991;85-87.
2. Biglione M, Vidan O, Mahieux R, De CM, de los Angeles de Basualdo, Bonnet M, et al. Seroepidemiological and molecular studies of human T cell lymphotropic virus type II, subtype b, in isolated groups of Mataco and Toba Indians of northern Argentina, AIDS Res Hum Retroviruses 1999;15:407-17.
3. Briggs N.C., Battjes R.J., Cantor K.P., Blattner W.A., Yellin F.M., Wilson S. et al. Seroprevalence of human T cell lymphotropic virus type II infection, with or without human immunodeficiency virus type 1 coinfection, among US intravenous drug users. J. Infect. Dis. 172:1995;51-58.
4. Chen I.S., Quan S.G., Golde D.W. Human T-cell leukemia virus type II transforms normal human lymphocytes. Proc. Natl. Acad. Sci. USA. 80:1983;7006-7009.
5. Dekaban G.A., Inwood M., Waters D., Drouin J., Teitel J. Absence of human T-lymphotropic virus types I and II infection in an Ontario hemophilia population. Transfusion. 32:1992;513-516.
6. Dekaban G.A., King E., Waters D., Rice G. Nucleotide sequence analysis of an HTLV-I isolate from a Chilean patient with HAM/TSP. AIDS Res. Hum. Retroviruses. 8:1992;1201-1207.
7. Dekaban G.A., Oger J.J.F., Foti D., King E.E., Waters D.J., Picard F.J. et al. HTLV-I infection associated with disease in aboriginal Indians from British Columbia: a serological and PCR analysis. Clin. Diagn. Virol. 2:1994;67-78.
8. Eiraku N., Novoa P., da Costa Ferreira M., Monken C., Ishak R., da Costa Ferreira O. et al. Identification and characterization of a new and distinct subtype of human T-cell lymphotropic virus type 2. J. Virol. 70:1996;1481-1492.
9. Felsenstein J. PHYLIP (Phylogeny Inference Package) version 3.5c. Seattle: Department of Genetics, University of Washington, 1985;
10. Gessain A, Mauclère P, Froment A, Biglione M, Le Hesran JY, Tekaia F, et al. Isolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), subtype B, from a healthy pygmy living in a remote area of Cameroon and ancient origin for HTLV-II in Africa, Proc Natl Acad Sci USA 1995;92:4041-5.
11. Goubau P., Liu H.F., De Lange G.G., Vandamme A.M., Desmyter J. HTLV-II seroprevalence in pygmies across Africa since 1970. AIDS Res. Hum. Retroviruses. 9:1993;709-713.
12. Harrington W.J.J., Sheremata W., Hjelle B., Dube D.K., Bradshaw P., Foung S.K. et al. Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann. Neurol. 33:1993;411-414.
13. Hjelle B., Appenzeller O., Mills R., Alexander S., Torrez-Martinez N., Jahnke R. et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet. 339:1992;645-646.
14. Hjelle B., Cyrus S., Swenson S.G. Evidence for sexual transmission of human T lymphotropic virus type II. Ann. Intern. Med. 116:1992;90-91.
15. Hjelle B., Mills R., Swenson S., Mertz G., Key C., Allen S. Incidence of hairy cell leukemia, mycosis fungoides, and chronic lymphocytic leukemia in first known HTLV-II-endemic population. J. Infect. Dis. 163:1991;435-440.
16. Jacobson S., Lehky T., Nishimura M., Robinson S., McFarlin D.E., Dhib-Jalbut S. Isolation of HTLV-II from a patient with chronic progressive neurological disease clinically indistinguishable from HTLV-I associated myelopathy/tropical spastic paraparesis. Ann. Neurol. 33:1993;392-396.
17. Kalyanaraman V.S., Sarngadharan M.G., Robert-Guroff M., Miyoshi I., Golde D., Gallo R.C. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Ann. NY Acad. Sci. 218:1982;571-573.
18. Kaplan M.H. Human retroviruses and neoplastic disease. Clin. Infect. Dis. 17(Suppl. 2):1993;S400-S406.
19. Kaplan M.H., Hall W.W., Susin M., Pahwa S., Salahuddin S.Z., Heilman C. et al. Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection. Am. J. Med. 91:1991;300-309.
20. Kaplan M.H., Sadick N.S., McNutt N.S., Talmor M., Coronesi M., Hall W.W. Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: a new association with intravenous drug abuse. J. Am. Acad. Dermatol. 29:1993;701-708.
21. Komurian-Pradel F., Pelloquin F., Sonoda S., Osame M., de The G. Geographical subtypes demonstrated by RFLP following PCR in the LTR region of HTLV-I. AIDS Res. Hum. Retroviruses. 8:1992;429-434.
22. Kumar S, Tamura K, Nei M. MEGA: molecular evolutionary genetics analysis, version 1.01. Pa: The Pennsylvania State University, University Park, 1993.
23. Lairmore M.D., Jacobson S., Gracia F., De B., Castillo L., Larreategui M. et al. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc. Natl. Acad. Sci. USA. 87:1990;8840-8844.
24. Lal R.B., Gongora-Biachi R.A., Pardi D., Switzer W.M., Goldman I., Lal A.F. Evidence for mother-to-child transmission of human T lymphotropic virus type II. J. Infect. Dis. 168:1993;586-591.
25. Lal R.B., Pardi D., Switzer W., Segurado A., Black F. Immune reactivity of HTLV-IIa-infected Kayapo Indians with HTLV-IIb extended Tax epitope. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 14:1997;476-477.
26. Lee H., Swanson P., Shorty V., Zack J., Rosenblatt J.D., Chen I.S.Y. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Ann. NY Acad. Sci. 244:1989;471-476.
27. Levine P.H., Jacobson S., Elliott R., Cavallero A., Colclough G., Dorry C. et al. HTLV-II infection in Florida Indians. AIDS Res. Hum. Retroviruses. 9:1993;123-127.
28. Loughran T.P.J., Coyle T., Sherman M.P., Starkebaum G., Ehrlich G.D., Ruscetti F.W. et al. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood. 80:1992;1116-1119.
29. Maloney E.M., Biggar R.J., Neel J.V., Taylor M.E., Hahn B.H., Shaw G.M. et al. Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J. Infect. Dis. 166:1992;100-107.
30. Manns A., Blattner W.A. The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease. Transfusion. 31:1991;67-75.
31. Martin M.P., Biggar R.J., Hamlin-Green G., Staal S., Mann D. Large granular lymphocytosis in a patient infected with HTLV-II. AIDS Res. Hum. Retroviruses. 9:1993;715-719.
32. Murphy E.L., Engstrom J.W., Miller K., Sacher R.A., Busch M.P., Hollingsworth C.G. HTLV-II associated myelopathy in 43-year-old woman. Lancet. 341:1993;757-758.
33. 0. Virology. 242:1998;425-434.
34. Oger J., Kastrukoff L., O'Gorman M., Paty D.W. Progressive multiple sclerosis: abnormal immune function in vitro and aberrant correlation with enumeration of lymphocyte subpopulations. J. Neuroimmun. 12:1986;37-48.
35. Oger J., Lu T., Aziz T., Gasoyne R.D., King E.E., Cummings H. et al. HTLV-II associated spinal cerebellar degeneration with high in-vitro proliferation, increased CD4+positive cells - no evidence of cell membrane activation. J. AIDS Hum. Retroviruses. 10:1995;228.
36. Osame M., Matsumoto M., Usuku K., Izumo S., Ijichi N., Amitani H. et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann. Neurol. 21:1987;117-122.
37. Pardi D., Kaplan J.E., Coligan J.E., Folks T.M., Lal R.B. Identification and characterization of an extended Tax protein in human T-cell lymphotropic virus type II subtype b isolates. J. Virol. 67:1993;7663-7667.
38. Picard F.J., Coulthart M.B., Oger J., King E.E., Kim S., Arp J. et al. Human T-lymphotropic virus type I (HTLV-I) in coastal natives of British Columbia: phylogenetic affinities and possible origins. J. Virol. 69:1995;7248-7256.
39. Picard F.J., Dekaban G.A., Silva M., Jury M.F., Rice G.P.A. Mollaret's meningitis associated with herpes simplex type II infection. Neurology. 43:1993;1722-1727.
40. Rosenblatt J.D., Golde D.W., Wachsman W., Giorgi J.V., Jacobs A., Schmidt G.M. et al. A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N. Engl. J. Med. 315:1986;372-377.
41. Rosenblatt J.D., Tomkins P., Rosenthal M., Kacena A., Chan G., Valderama R. et al. Progressive spastic myelopathy in a patient co-infected with HIV-1 and HTLV-II: autoantibodies to the human homologue of rig in blood and cerebrospinal fluid. AIDS. 6:1992;1151-1158.
42. Rzhetsky A., Nei M. A simple method for estimating and testing minimum-evolution trees. Mol. Biol. Evol. 9:1992;945-967.
43. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:1987;406-425.
44. Salemi M., Vandamme A.M., Gradozzi C., Van L.K., Cattaneo E., Taylor G. et al. Evolutionary rate and genetic heterogeneity of human T-cell lymphotropic virus type II (HTLV-II) using isolates from European injecting drug users. J. Mol. Evol. 46:1998;602-611.
45. Sheremata W.A., Harrington W.J.J., Bradshaw P.A., Foung S.K., Raffanti S.P., Berger J.R. et al. Association of '(tropical) ataxic neuropathy' with HTLV-II. Virus Res. 29:1993;71-77.
46. Shimotohno K., Takahashi K., Shimizu N., Gojobori T., Golde D., Chen I.S.Y. et al. Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene. Proc. Natl. Acad. Sci. USA. 82:1985;3101-3105.
47. Soriano V., Calderon E., Esparza B., Cilla G., Aguilera A., Gutierrez M. et al. HTLV-I/II infections in Spain. The HTLV-I/II spanish study group. Int. J. Epidemiol. 22:1993;716-719.
48. Stuver S.O., Mueller N.E. Re: 'Sexual transmission of human T-lymphotropic virus type I among female prostitutes and among patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan'. Am. J. Epidemiol. 142:1995;1247-1248.
49. Switzer W.M., Pieniazek D., Swanson P., Samdal H.H., Soriano V., Khabbaz R.F. et al. Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J. Virol. 69:1995;621-632.
50. Tarsis S.L., Yu M.T., Parks E.S., Persaud D., Munoz J.L., Parks W.P. Human T-lymphocyte transformation with human T-cell lymphotropic virus type 2. J. Virol. 72:1998;841-846.
51. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic. Acids Res. 22:1994;4673-4680.
52. Vignoli C., Zandotti C., De Lamballerie X., Tamalet C., Gastaut J.A., De Micco P. Prevalence of HTLV-II in HIV-1-infected drug addicts in Marseille. Eur. J. Epidemiol. 9:1993;351-352.
53. Zehender G., De Maddalena C., Osio M., Cavalli B., Parravicini C., Moroni M. et al. High prevalence of human T cell lymphotropic virus type II infection in patients affected by human immunodeficiency virus type 1 - associated predominantly sensory polyneuropathy. J. Infect. Dis. 172:1995;1595-1598.
54. Zella D, Mori M, Sala M, Ferrante P, Casoli C, Magnani G et al. HTLV-II infection in Italian drug abusers. Lancet. ii:1990;575-576.